Trade Setup For May 6: Nifty 50 Finds Resistance Near 24,500 Levels
Australian share indices were trading in a narrow range in early trade Tuesday. Financial markets in Japan and South Korea are closed. China will re-open after a holiday.
The S&P ASX 200 was trading flat at 8,157.90 as of 6:48 a.m.
On Monday, Dow Jones Industrial Average and S&P 500 ended 0.24% and 0.64% down, respectively. The Nasdaq Composite index ended 0.74% down.
The Bloomberg dollar index was at 100.05. The Bloomberg spot gold was 0.83% up at $3,361.72 an ounce as of 6:51 a.m. Brent crude was trading 1% higher at $60.83 a barrel.
The GIFT Nifty was trading flat at 24,593.50 as of 6:52 a.m.
The NSE Nifty 50 continues to find resistance near the 24,500 levels, despite closing the market with gains for a second consecutive session on Monday, according to Aditya Gaggar, director of Progressive Shares Brokers.
A sustained move above this threshold could push the frontline index further towards 24,630 levels, the analyst said.
In case of a downside, Nifty 50 may find immediate support at 24,360 levels, Gaggar added.
The index has formed a small bullish candle on the daily charts, as per Shrikant Chouhan, head of equity research, Kotak Securities. Looking at intraday charts, the price action is currently forming a pattern that suggests the existing uptrend will continue, he added.
Chouhan said that 24,375 level would act as a key support zone, and the if the index moves higher, then it can test the levels of 24,600-24,675.
"On the other side, dismissal of 24,375 could trigger a quick intraday correction. Below the same, market could retest the level of 24,300-24,250," he added.
The Bank Nifty, a keenly tracked index, faces resistance in the zone of 55,700 to 56,000, said Hrishikesh Yedve, assistant vice president of technical and derivatives research at Asit C. Mehta Investment Interrmediates. The support lies at 54,450, he added.
"A firm break below 54,450 may trigger fresh selling pressure, potentially dragging the index towards 54,000. Until then, a range-bound consolidation between 54,450 and 56,000 may continue," Yedve said.
Market Recap
India's benchmark equity indices ended higher for the second session in a row on Monday.
The NSE Nifty 50 closed 0.47% higher at 24,461.15, while the BSE Sensex ended 0.37% up at 80,796.84.
HDFC Bank Ltd.'s share price closed 0.61% higher at Rs 1,936. 80 apiece, while Mahindra & Mahindra Ltd. closed 3.26% higher at Rs 3,021.50 per share.



FII/DII Activity
Foreign portfolio investors stayed net buyers of Indian equities for the 13th straight session on Monday, as they bought stocks worth Rs 497.79 crore.
Domestic institutional investors remained net buyers for the sixth session in a row, mopping up equities worth Rs 2,788.66 crore, according to provisional data from the National Stock Exchange.
F&O Cues
Nifty May Futures up by 0.68% at 24,567 at a premium of 106 points.
Nifty May futures open interest up by 4.5%.
Nifty Options May 8 Expiry: Maximum Call open interest at 26,000 and Maximum Put open interest at 24,000.
Put-Call ratio at 0.77, with the highest change in Call open interest at 24,500.
Securities in ban period: RBL Bank, Manappuram Finance.

Major Stocks In The News
Senores Pharma: The company signed an agreement with Wockhardt to acquire USFDA-approved Topiramate tablets, used to treat epilepsy and migraine. The market size of Topiramate Tablet in the US was $111.47 million.
Paras Defence: The company signed an MoU with Israel-based Heven Drones to create new opportunities and expand both parties' business in the defence sector. The parties intend to form a JV company in India.
Glenmark Pharma: Ichnos Glenmark Innovation received USFDA fast-track status for ISB 2001, used to treat adult patients with relapsed or refractory multiple myeloma.
ONGC: The company completed the offshore facilities decommissioning project along with Reliance Industries and Shell.
Currency Market
The Indian rupee closed 31 paise stronger at 84.25 against the US dollar on Monday, according to Bloomberg data.
The local currency had closed at 84.56 against the greenback on Friday.

-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.